Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Biogenomics Limited, is an unlisted public company incorporated on 24 April, 2002. It is classified as a public limited company and is located in , . It's authorized share capital is INR 390.02 cr and the total paid-up capital is INR 383.51 cr.
Biogenomics Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2021.
Read more
** All rupee values in INR lacs. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Namit Rustagi | 09493933 | 3 years |
Whole-time Director | Archana Rajesh Krishnan
Shareholder
|
00208511 | 19 years |
Nominee Director | Pushkar Jauhari | 06391650 | 3 years |
Nominee Director | Ali Abdullah Ali Al Aamri | 09608439 | 3 years |
Director | Ammar Abdullah Hamad Al Ali | 09538218 | 3 years |
Nominee Director | Mohammed Hamdan Saif Al Rubaie | 09615093 | 3 years |
Nominee Director | Imran Jamiluddin Shaikh | 10723912 | 1 years |
Director | Rajesh Shashikant Dalal | 03504969 | 2 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Standard Chartered Bank
No. of Loans: 1
Total Amount : 4.0 cr
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
CYTOMEDICINES (INDIA) PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
REFLEX TECHNOLOGIES PRIVATE LIMITED |
Active
|
71.6 L | 1 | Maharashtra |
LAXMI DENTAL PRIVATE LIMITED |
Active
|
17.2 Cr | 1 | Maharashtra |
ENTERO HEALTHCARE SOLUTIONS LIMITED |
Active
|
35.5 Cr | 1 | Haryana |
ASCENT MEDITECH LIMITED |
Active
|
1.2 Cr | 1 | Gujarat |
LAXMI DENTAL PRIVATE LIMITED |
Active
|
17.2 Cr | 1 | Maharashtra |
AJANTA PHARMA LIMITED |
Active
|
25.2 Cr | 1 | |
NAFFA INNOVATIONS PRIVATE LIMITED |
Active
|
8.1 L | 1 | |
EDUNETWORK PRIVATE LIMITED |
Active
|
67.0 L | 1 | |
JUPITER INTERNATIONAL LIMITED |
Active
|
16.0 Cr | 1 |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Biogenomics International SPC | Oman | - | - |
Read more
The incorporation date of BIOGENOMICS LIMITED is 24 April, 2002
The authorized share capital of BIOGENOMICS LIMITED is INR ₹ 390.0 Cr.
The paid-up capital of BIOGENOMICS LIMITED is INR ₹ 383.5 Cr.
The registered address of BIOGENOMICS LIMITED is R. S. No. 139, Manapet Road, Kanniakoil, Manapet Village, Bahour Commune, Pondicherry, Manapeth, Pondicherry, Pondicherry, Pondicherry, India, 607402 - 607402
The CIN number of BIOGENOMICS LIMITED is U24234PY2002PLC009158.